1. Home
  2. DALN vs FBIO Comparison

DALN vs FBIO Comparison

Compare DALN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DALN
  • FBIO
  • Stock Information
  • Founded
  • DALN 1954
  • FBIO 2006
  • Country
  • DALN United States
  • FBIO United States
  • Employees
  • DALN N/A
  • FBIO N/A
  • Industry
  • DALN Newspapers/Magazines
  • FBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DALN Consumer Discretionary
  • FBIO Health Care
  • Exchange
  • DALN Nasdaq
  • FBIO Nasdaq
  • Market Cap
  • DALN 79.8M
  • FBIO 88.7M
  • IPO Year
  • DALN 2008
  • FBIO N/A
  • Fundamental
  • Price
  • DALN $15.84
  • FBIO $3.55
  • Analyst Decision
  • DALN
  • FBIO Strong Buy
  • Analyst Count
  • DALN 0
  • FBIO 2
  • Target Price
  • DALN N/A
  • FBIO $16.50
  • AVG Volume (30 Days)
  • DALN 65.6K
  • FBIO 1.3M
  • Earning Date
  • DALN 11-11-2025
  • FBIO 11-13-2025
  • Dividend Yield
  • DALN N/A
  • FBIO N/A
  • EPS Growth
  • DALN N/A
  • FBIO N/A
  • EPS
  • DALN N/A
  • FBIO N/A
  • Revenue
  • DALN $121,119,000.00
  • FBIO $59,301,000.00
  • Revenue This Year
  • DALN N/A
  • FBIO $51.59
  • Revenue Next Year
  • DALN N/A
  • FBIO $44.74
  • P/E Ratio
  • DALN N/A
  • FBIO N/A
  • Revenue Growth
  • DALN N/A
  • FBIO N/A
  • 52 Week Low
  • DALN $3.66
  • FBIO $1.33
  • 52 Week High
  • DALN $16.10
  • FBIO $3.97
  • Technical
  • Relative Strength Index (RSI)
  • DALN 73.38
  • FBIO 67.94
  • Support Level
  • DALN $14.22
  • FBIO $3.26
  • Resistance Level
  • DALN $14.87
  • FBIO $3.97
  • Average True Range (ATR)
  • DALN 0.17
  • FBIO 0.30
  • MACD
  • DALN -0.11
  • FBIO 0.09
  • Stochastic Oscillator
  • DALN 91.53
  • FBIO 75.15

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: